Anúncios importantes

Atualização da Política de Não Discriminação

O Boston Medical Center Health System cumpre as leis federais de direitos civis aplicáveis ​​e não discrimina com base em idade, raça, cor, origem nacional (incluindo proficiência limitada em inglês e idioma principal), religião, cultura, deficiência física ou mental, status socioeconômico, sexo, orientação sexual e identidade e/ou expressão de gênero. O BMCHS oferece ajuda e serviços gratuitos para pessoas com deficiência e serviços linguísticos gratuitos para pessoas cujo idioma principal não é o inglês.

Para ler nossa Declaração de Não Discriminação completa, clique aqui.

Academic Publications

Select your language:

  • Vasan RS, Massaro JM, Wilson PW, Seshadri S, Wolf PA, Levy D, D'Agostino RB. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2002;105:48-53.
  • Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-10.
  • Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346: 476-83.
  • Seshadri S, Wolf PA. Homocysteine and dementia - Reply. N Engl J Med 2002; 346: 2008.
  • Tan ZS, Seshadri S, Beiser A, Wilson PW, Keil DP, Tocco M, D'Agostino RB, Wolf PA. Plasma cholesterol level as a risk factor for Alzheimer's disease: the Framingham Study. Arch Intern Med 2003; 163:1053-7.
  • Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004;35: 404-409.
  • Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke 2004;35:1264-69.
  • Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35:1857-61.
  • Seshadri S, Wolf PA, Besier A, Elias MF, Au R, Kase CS, D'Agostino RB, DeCarli C. Stroke risk profile, brain volume and cognitive function: the Framingham Offspring Study. Neurology 2004;63:1591-99.
  • Seshadri S, Beiser A, Ivan CS, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Does preventing stroke prevent all kinds of dementia? Response. Stroke 2004;35: 2437.
  • Au R, Seshadri S, Wolf PA, Sullivan L, D'Agostino RB. New norms for a new generation: cognitive performance in the Framingham
  • Offspring Cohort. Experimental Aging Research 2004;30:333-358.
  • Tan ZS, Seshadri S, Beiser A, et al. Bone mineral disease and the risk of Alzheimer's disease. Arch Neurol 2005;62:107-111.
  • Ellias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham Offspring Study: age is important. Am J Epidemiol 2005;162:644-53.
  • Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Temporal trends in incidence, lifetime risk, severity and mortality of stroke over the past fifty years. JAMA 2006;296:2939-46.
  • Das RR, Seshadri S, Beiser AS, Himali JJ, Au R, Kelly-Hayes M, Kase CS, Benjamin EJ, Polak JF, O'Donnell CJ, D'Agostino RB, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring. Stroke 2008 [in press].

Abstracts presented at national and international meetings in last 5 years, not yet published

  • Auerbach SH, Au R, Beiser A, Seshadri S, Wolf PA. Mild cognitive impairment: 25 year follow-up in the Framingham Study. Neurology 2003; 60 (Suppl 1): A244.
  • Najarian R, Seshadri S, Beiser A, Au R, Wolf PA. Blood pressure, weight loss and Alzheimer's disease: insights from the Framingham Study. Neurology 2003;60 (Suppl 1):A207.
  • Seshadri S, Beiser A, Vasan RS, DeCarli C, Wang TJ, Au R, Larson MG, Levy D, Wolf PA. Association of plasma atrial and B-type natriuretic peptides in silent cerebral infarcts and white matter hyperintensity on brain magnetic resonance imaging. Stroke 2004;35:314.
  • Romero JR, Seshadri S, Beiser A, DeCarli C, Au R, Ramachandran V, Wolf PA. Matrix metalloproteinases are associated with MRI indices of brain ischemia and aging: the Framingham Study. Neurology 2006;66 (Suppl2):A318.
  • Albert M, Au R, Massaro JM, Seshadri S, Wolf PA, DeCarli C. Sex differences on brain MRI and cognition in Framingham Offspring Study. Neurology 2007;68;(Suppl 1):A168.
  • Pikula A, Böger RH, Beiser A, Maas R, DeCarli C, Schwedhelm E, Du Y, Schulze F, Au R, Kelly-Hayes M, Kase CS, Vasan RS, Wolf PA, Seshadri S. Plasma asymmetric dimethylarginine levels are associated with silent cerebral infarcts: the Framingham Study. Platform presentation at 60th AAN Annual Meeting in Chicago, IL. Neurology April, 2008.
  • Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Stroke in Women - Gender Differences in Stroke Incidence and Post-stroke Disability in the Framingham Heart Study. Stroke Feb. 2008;39:551.